These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 29053621

  • 1. Isoproterenol Increases RANKL Expression in a ATF4/NFATc1-Dependent Manner in Mouse Osteoblastic Cells.
    Baek K, Park HJ, Baek JH, Kim HR.
    Int J Mol Sci; 2017 Oct 20; 18(10):. PubMed ID: 29053621
    [Abstract] [Full Text] [Related]

  • 2. The cooperation of CREB and NFAT is required for PTHrP-induced RANKL expression in mouse osteoblastic cells.
    Park HJ, Baek K, Baek JH, Kim HR.
    J Cell Physiol; 2015 Mar 20; 230(3):667-79. PubMed ID: 25187507
    [Abstract] [Full Text] [Related]

  • 3. TNFα Increases RANKL Expression via PGE₂-Induced Activation of NFATc1.
    Park HJ, Baek K, Baek JH, Kim HR.
    Int J Mol Sci; 2017 Feb 24; 18(3):. PubMed ID: 28245593
    [Abstract] [Full Text] [Related]

  • 4. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.
    Balkan W, Martinez AF, Fernandez I, Rodriguez MA, Pang M, Troen BR.
    Gene; 2009 Oct 15; 446(2):90-8. PubMed ID: 19563866
    [Abstract] [Full Text] [Related]

  • 5. High extracellular calcium-induced NFATc3 regulates the expression of receptor activator of NF-κB ligand in osteoblasts.
    Lee HL, Bae OY, Baek KH, Kwon A, Hwang HR, Qadir AS, Park HJ, Woo KM, Ryoo HM, Baek JH.
    Bone; 2011 Aug 15; 49(2):242-9. PubMed ID: 21514407
    [Abstract] [Full Text] [Related]

  • 6. RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation.
    Sundaram K, Nishimura R, Senn J, Youssef RF, London SD, Reddy SV.
    Exp Cell Res; 2007 Jan 01; 313(1):168-78. PubMed ID: 17084841
    [Abstract] [Full Text] [Related]

  • 7. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD, Kim HN, Lee JH, Jin WJ, Hwang SJ, Kim HH, Ha H, Lee ZH.
    Biochem Pharmacol; 2013 Sep 15; 86(6):782-90. PubMed ID: 23928189
    [Abstract] [Full Text] [Related]

  • 8. Receptor activator of nuclear factor-kappaB ligand-induced nuclear factor of activated T cells (C1) autoregulates its own expression in osteoclasts and mediates the up-regulation of tartrate-resistant acid phosphatase.
    Fretz JA, Shevde NK, Singh S, Darnay BG, Pike JW.
    Mol Endocrinol; 2008 Mar 15; 22(3):737-50. PubMed ID: 18063694
    [Abstract] [Full Text] [Related]

  • 9. Arctigenin inhibits osteoclast differentiation and function by suppressing both calcineurin-dependent and osteoblastic cell-dependent NFATc1 pathways.
    Yamashita T, Uehara S, Udagawa N, Li F, Kadota S, Esumi H, Kobayashi Y, Takahashi N.
    PLoS One; 2014 Mar 15; 9(1):e85878. PubMed ID: 24465763
    [Abstract] [Full Text] [Related]

  • 10. NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.
    Crotti TN, Flannery M, Walsh NC, Fleming JD, Goldring SR, McHugh KP.
    Gene; 2006 May 10; 372():92-102. PubMed ID: 16513293
    [Abstract] [Full Text] [Related]

  • 11. Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells.
    Kim JM, Lee JH, Lee GS, Noh EM, Song HK, Gu DR, Kim SC, Lee SH, Kwon KB, Lee YR.
    BMC Complement Altern Med; 2017 Mar 23; 17(1):164. PubMed ID: 28335757
    [Abstract] [Full Text] [Related]

  • 12. Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.
    Hong G, Zhou L, Shi X, He W, Wang H, Wei Q, Chen P, Qi L, Tickner J, Lin L, Xu J.
    Int J Mol Sci; 2017 Jan 19; 18(1):. PubMed ID: 28106828
    [Abstract] [Full Text] [Related]

  • 13. CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis.
    Tsushima H, Okazaki K, Ishihara K, Ushijima T, Iwamoto Y.
    Arthritis Res Ther; 2015 Feb 17; 17(1):31. PubMed ID: 25811130
    [Abstract] [Full Text] [Related]

  • 14. Osteoporosis regulation by salubrinal through eIF2α mediated differentiation of osteoclast and osteoblast.
    He L, Lee J, Jang JH, Sakchaisri K, Hwang J, Cha-Molstad HJ, Kim KA, Ryoo IJ, Lee HG, Kim SO, Soung NK, Lee KS, Kwon YT, Erikson RL, Ahn JS, Kim BY.
    Cell Signal; 2013 Feb 17; 25(2):552-60. PubMed ID: 23178987
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB.
    Koide N, Kondo Y, Odkhuu E, Ulziisaikhan J, Ukaji T, Yokochi T, Umezawa K.
    Immunol Lett; 2014 Sep 17; 161(1):31-7. PubMed ID: 24792671
    [Abstract] [Full Text] [Related]

  • 16. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X, Li Z, Yang Z, Zheng C, Jing J, Chen Y, Ye X, Lian X, Qiu W, Yang F, Tang J, Xiao J, Liu M, Luo J.
    J Bone Miner Res; 2012 Jun 17; 27(6):1298-1308. PubMed ID: 22337253
    [Abstract] [Full Text] [Related]

  • 17. Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation.
    Song I, Kim JH, Kim K, Jin HM, Youn BU, Kim N.
    FEBS Lett; 2009 Jul 21; 583(14):2435-40. PubMed ID: 19576893
    [Abstract] [Full Text] [Related]

  • 18. Pueraria lobate Inhibits RANKL-Mediated Osteoclastogenesis Via Downregulation of CREB/PGC1β/c-Fos/NFATc1 Signaling.
    Park KH, Gu DR, Jin SH, Yoon CS, Ko W, Kim YC, Lee SH.
    Am J Chin Med; 2017 Jul 21; 45(8):1725-1744. PubMed ID: 29121799
    [Abstract] [Full Text] [Related]

  • 19. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
    Lee JH, Jin H, Shim HE, Kim HN, Ha H, Lee ZH.
    Mol Pharmacol; 2010 Jan 21; 77(1):17-25. PubMed ID: 19828731
    [Abstract] [Full Text] [Related]

  • 20. 25-hydroxycholesterol promotes RANKL-induced osteoclastogenesis through coordinating NFATc1 and Sp1 complex in the transcription of miR-139-5p.
    Zhang L, Lv Y, Xian G, Lin Y.
    Biochem Biophys Res Commun; 2017 Apr 15; 485(4):736-741. PubMed ID: 28257846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.